65,437 trials
Seborrheic Keratosis (SK)
Primary: Mean Change in Physician Lesion Assessment Scale — -0.47; -0.88; -1.12; -0.15 Change in Score on a scale
Diabetes Mellitus, Type 2 · Albuminuria
Primary: Progression of Albuminuria — 153.01; 99.80 Events per 1000 patient-year — p=<.0001
Safety, Pharmacokinetics, Pharmacodynamics, Food Effect
Primary: Safety and Tolerability of AZD7986 by Assessment of the Number of Adverse Events (AEs) Following Administration of Oral Solution in Single Ascending Dose (SAD - Part 1a…
Adherence
Primary: Use of Portal724-MEMS Service on Medication Adherence in the Treatment of Hepatitis C in Patients, Defined as Compliance to Regimen 95% of the Time. — 19; 18…
cUTI
Primary: Participants In The Microbiological Intent-To-Treat (Micro-ITT) Population With A Responder Outcome At The Post-Treatment (PT) Visit — 180; 202; 100; 91 Participants
Accidental Falls
Primary: Fall Related Process Measures — 3.3; 3.2 number of fall risk reduction indicators
Emotional Disorders · Anxiety Disorders
Primary: Anxiety Disorders Interview Schedule for DSM-IV — 5.23; 5.09; 3.18; 5.14 score on a scale
Castration Levels of Testosterone · Castration-Resistant Prostate Carcinoma · Metastatic Prostate Carcinoma
Primary: Quantification of T-cell Responses to Prostatic Acid Phosphatase Granulocyte-macrophage Colony-stimulating Factor (PAP-GM-CSF), Assessed by Quantification of Interferon…
Xerostomia
Primary: Change in Percentage of Time With CPAP (Continuous Positive Airway Pressure) Usage — -5.09; 11.67 percentage of time
Cholesterol Ester Storage Disease(CESD) · Lysosomal Acid Lipase Deficiency · LAL-Deficiency
Primary: Number Of Participants Reporting TEAEs And Infusion-Related Reactions (IRRs) — 1; 3; 3; 0 participants
Mobility Limitation
Primary: Leg Extensor Muscle Power — 32.9; 41.6 Watts
Unilateral Acoustic Neuroma · Meniere's Disease
Primary: Change in Consonant-Nucleus-Consonant (CNC) Words Scores Over Time — 23.6; 22; 18.8; 42.7 Percentage of words correct
Ureterolithiases
Primary: Proportion of Patients Passing Their Stone Within 28 Days by Self Report — 128; 113 Participants
Cancer · Giant Cell Tumors · Giant Cell Tumor of Bone
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 260; 231; 12; 98 Participants
Tobacco Abstinence Syndrome
Primary: Amount Eaten in Taste Test — 124; 116 grams